Early occurrence of acute myeloid leukemia following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast

Indian Journal of Cancer

Volumn 41, Issue 4, 2004, Pages 178-180

  Srivastava, A ^a   Murari, M ^a   Datta, N R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer breast; Chemotherapy; Leukemia; Radiotherapy; Second malignancy

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CASE REPORT; DRUG DOSE REGIMEN; FEMALE; HUMAN; MASTECTOMY; PLEURA EFFUSION; PLEURODESIS; SALVAGE THERAPY;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY;

EID: 13444278638     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. nd Ed. New York: Oxford University Press; p. 319-41.
2. Curtis RE, Boice JD, Stovall M, Bernstein L, Greenberg RS, Flannery JT, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-51.
3. th Ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 371-2.
4. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001;344:1997-08.
5. Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, et al. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: The Eastern Cooperative Oncology Group Experience. J Clin Oncol 1995;13:1557-63.
6. Cutuli B, Janvier M, de la Rochefordiere A, Julien JP, Isambert N, Alzieu C et al. Leukemia and preleukemic conditions occurring after treatment of breast cancer. Presse Med 2000;29:135-8.